Who Owns Vicks?

• Parent Company: Procter & Gamble Company
• Ownership Type: Wholly owned
• Acquisition Year: 1985
• Company Type: Publicly Traded
• Stock Ticker: NYSE: PG

• Founded: 1890
• Founders: Lunsford Richardson
• Acquired by Procter & Gamble Company: 1985

• Founded: 1837
• Headquarters: Cincinnati, Ohio, USA
• Company Type: Publicly Traded
• Stock: NYSE: PG
• Revenue: approximately $84 billion (FY2025)
• Employees: Approximately 107,000

Visit Procter & Gamble Company website

• Headquarters: Cincinnati, Ohio, USA
• Manufacturing / Operations: United States, Mexico, China, India, Various international locations

Vicks operates under Procter & Gamble's comprehensive sustainability framework, guided by the company's commitment to environmental responsibility, social impact, and ethical business practices. P&G has set ambitious sustainability goals including achieving net zero greenhouse gas emissions by 2040 and reducing Scope 1 and 2 emissions by 65% by 2030 from a 2022 baseline. The company aims to purchase 100% renewable electricity by 2030, with more than 99% already sourced from renewable sources globally, and is working toward designing all consumer packaging to be recyclable or reusable by 2030.

Climate Action and Net Zero Commitment: P&G's net zero ambition spans across the entire supply chain from raw material to retailer by 2040, with intermediate targets including a 65% reduction in Scope 1 and 2 emissions by 2030. The company's total carbon footprint was 2,159,908 tCO2e in 2024, with Scope 1 and 2 emissions representing approximately 2% of the total footprint. Vicks manufacturing facilities participate in these climate initiatives through energy efficiency improvements, renewable energy adoption, and emissions reduction programs. The company has accelerated its efforts through the P&G Climate Unlock Program, which helps suppliers in their climate progress and transition to net zero through education, resources, and training.

Sustainable Packaging and Waste Reduction: Vicks contributes to P&G's ambitious packaging goals by 2030, aiming to design all consumer packaging to be recyclable or reusable while reducing virgin petroleum plastic use by 50% per unit of production versus a 2017 baseline. The brand has implemented sustainable packaging initiatives for VapoRub containers, liquid medication bottles, and packaging innovations that improve recyclability while maintaining product safety and efficacy. Vicks also participates in waste reduction programs at manufacturing facilities, working toward circular economy principles in pharmaceutical packaging and reducing environmental impact across the product lifecycle.

Renewable Energy and Resource Efficiency: Vicks manufacturing facilities benefit from P&G's transition to renewable electricity, which reached 99% globally in 2024. The company has implemented energy efficiency improvements, water conservation programs, and waste reduction initiatives at Vicks production sites. These operational improvements not only reduce environmental impact but also deliver cost savings and enhance manufacturing efficiency. Vicks has invested in green building standards and energy-efficient equipment across its manufacturing network to minimize the carbon footprint of production operations.

Supply Chain Engagement and Innovation: P&G works closely with hundreds of suppliers and partners to improve environmental performance across the value chain. Vicks supports these supplier engagement initiatives through partnerships with raw material suppliers, packaging manufacturers, and distribution companies. The company's supplier programs focus on energy efficiency, waste reduction, and innovation in sustainable technologies. Vicks collaborates with P&G to facilitate technical and financial support for suppliers to improve operational efficiency and reduce environmental impacts, particularly in pharmaceutical manufacturing and packaging processes.

Community Impact and Social Responsibility: Vicks operates under P&G's community engagement framework, supporting local communities through health education programs, hygiene awareness campaigns, and family welfare initiatives. The brand contributes to community health through educational programs about cold and flu prevention, supporting healthcare access in underserved communities, and promoting public health awareness. Vicks also participates in P&G's broader social impact programs focused on maternal and child health, education, and community development in regions where the brand operates.

Ethical Business Practices: Vicks maintains strict compliance with pharmaceutical regulations and ethical business practices throughout its operations. The company maintains transparency in its supply chain through regular sustainability reporting and third-party audits. Vicks adheres to FDA regulations for over-the-counter medications, ensuring product safety, efficacy, and accurate labeling. The brand also maintains rigorous quality control standards across all manufacturing facilities and distribution channels to protect consumer health and safety.

Vicks has received extensive recognition for product innovation, health education, and brand leadership throughout its 130+ year history. The brand's most notable achievements include multiple awards from healthcare organizations and consumer advocacy groups for cold and flu treatment effectiveness, product safety, and consumer trust in over-the-counter medications.

Product Innovation Awards: Vicks has received recognition from pharmaceutical organizations and medical associations for developing advanced cold and flu treatment formulations, improved delivery systems, and enhanced symptom relief technologies. The brand's various formulations including VapoRub, NyQuil, DayQuil, and VapoInhaler have consistently received top ratings from medical publications and consumer testing organizations for efficacy and safety in cold and flu symptom relief.

Consumer Trust and Safety Recognition: Vicks has been honored by consumer testing organizations and health publications for product quality, reliability, and consumer satisfaction. The brand's consistent performance in consumer satisfaction surveys demonstrates the brand's ability to maintain consumer trust while delivering effective cold and flu relief across multiple product categories.

Health Education Awards: Marketing and public health campaigns have been honored by healthcare organizations for effective consumer education about proper cold and flu prevention practices and responsible medication use. The brand's campaigns that promote cold season preparedness and proper symptom management have been acknowledged for contributing to public health education and responsible self-care practices.

Industry Recognition extends to P&G's overall corporate responsibility practices, with the company receiving awards for workplace diversity, sustainability initiatives, and ethical business practices in consumer goods manufacturing. Vicks has been acknowledged for its role in advancing public health through accessible cold and flu remedies and its contribution to global health awareness through reliable and affordable OTC solutions.

Longevity and Heritage Recognition: Vicks has received special recognition for its remarkable 130-year heritage as a trusted cold and flu remedy brand, with awards from historical societies and cultural organizations for maintaining brand relevance and consumer trust across generations. The brand's consistent presence in American households has been acknowledged as a significant achievement in consumer brand longevity and cultural impact.

Vicks has maintained a strong safety record throughout its 130+ year history, with no major product recalls or significant safety controversies. However, as a widely used over-the-counter medication brand, Vicks has faced typical pharmaceutical industry challenges and occasional scrutiny related to regulatory compliance, product formulations, and industry-wide issues affecting the consumer healthcare sector.

Regulatory Compliance Challenges: Vicks operates under strict regulatory oversight from the FDA and other health authorities for over-the-counter medications. The brand has maintained compliance with evolving regulatory requirements for OTC drug labeling, safety testing, and health claims across all markets. Vicks has adapted to changing regulatory requirements regarding ingredient disclosure, product claims, and safety standards while maintaining strict quality control systems across all manufacturing facilities.

Product Formulation and Safety Questions: Vicks has faced occasional questions about product formulations and ingredient safety, particularly regarding menthol content in VapoRub and potential allergic reactions in sensitive individuals. The brand has responded through enhanced ingredient transparency, clearer usage instructions, and the introduction of hypoallergenic product lines for consumers with sensitive skin or respiratory conditions. Vicks maintains comprehensive safety monitoring programs and clinical testing to ensure product efficacy and consumer safety.

Competition and Market Pressures: Vicks faces intense competition in the OTC cold and flu market from specialized pharmaceutical brands like Robitussin (Haleon), Mucinex (Reckitt), Theraflu (Haleon), and numerous store-brand cold remedies. The brand has navigated challenges related to pricing pressure from store-brand alternatives, changing consumer preferences for natural remedies, and regulatory requirements for OTC drug claims. Vicks has responded through product innovation, scientific validation programs, and maintaining its positioning as a trusted and reliable cold and flu solution while adapting to evolving consumer preferences.

Industry-Wide Challenges: Like all pharmaceutical companies, Vicks has been affected by broader industry challenges including changing consumer preferences toward natural and organic options, rising raw material costs, and growing competition from specialized health brands. P&G has addressed these challenges through product innovation, scientific validation programs, and maintaining strict quality control standards across all manufacturing facilities while adapting to evolving consumer preferences for natural and sustainable options.

Consumer Education and Misinformation: Vicks has faced challenges related to consumer education about proper OTC medication use and potential misuse of cold remedies. The brand has responded through enhanced educational campaigns, clearer usage instructions, and consumer awareness programs about responsible medication practices while maintaining scientific credibility and medical endorsements.